Summary. The study of dynamical models of HIV infection, based on a system of non-linear Ordinary Differential Equations (ODE), has considerably improved the knowledge of its pathogenesis. While the first models used simplified ODE systems and analyzed each patient separately, recent works dealt with inference in non-simplified models borrowing strength from the whole sample. The complexity of these models leads to great difficulties for inference and only the Bayesian approach has been attempted by now. We propose a full likelihood inference, adapting a Newton-like algorithm for these particular models. We consider a relatively complex ODE model for HIV infection and a model for the observations including the issue of detection limits. We apply this approach to the analysis of a clinical trial of antiretroviral therapy (ALBI ANRS 070) and we show that the whole algorithm works well in a simulation study.
Introduction
Studies of the human immunodeficiency virus (HIV) dynamics using biomathematical models have considerably improved the knowledge of the pathogenesis of this infection. For instance, such studies have demonstrated the high turnover of infected cells as well as that of free virions (Ho et al., 1995; Perelson et al., 1996) . These pioneering works considered models based on a system of non-linear Ordinary Differential Equations (ODE) without closedform solution, which were simplified and linearized. The estimation of the parameters was then performed for each subject using simple non-linear regression methods (Perelson et al., 1996) . Population approaches that estimate parameters of simplified models using the data from all the subjects of a sample have been proposed (Wu and Ding, 1999) : such models are in the framework of Non-Linear Mixed-Effect (NLME) models (Pinheiro and Bates, 2000) . However, as noted by Huang et al. (2006) , these linearized ODE models are not able to describe the course of the infection for a long-term period.
Moreover, only the virus dynamics is taken into account, neglecting the evolution of the CD4+ T lymphocytes (CD4) count. Last, these models do not include parameters such as treatment efficacy, and thus do not help much to a better understanding of the mechanisms of the infection or an evaluation of treatment effect: this is why it is important to work with non-simplified models (that is, based on non-linear ODE systems) which are able to represent the complexity of the dynamics. Several authors (Putter et al., 2002; Huang et al., 2006) have attacked the ambitious program of treating these models in a population context, all using a Bayesian approach. The two above-mentioned difficulties are combined: non closed-form of the solution 2 of the ODE system and numerical integrals involved in the likelihood. In the Bayesian approach the direct numerical integrations are avoided and the approach relies on the MCMC algorithms to give the a posteriori distributions of the parameters (Gilks et al., 1996) . Of course a priori distributions have to be given, and this is both an advantage (a priori knowledge can be put in the model) and a drawback (it is not always clear what quantity of a priori knowledge has been introduced) of the approach.
Although the Bayesian approach may be very attractive in such a complex problem, the maximum likelihood approach retains some advantages: there is no need to specify a priori distributions, and there is a very well established theory of inference, one can easily compare parametric models using the Akaike criterion. Moreover, Newton-like methods may be relatively fast compared to the heavy computation involved in Bayesian approach, convergence criteria are well defined and last, at convergence, the algorithm gives the maximum likelihood and an approximation of its second derivative, which is an estimate of the information matrix. To avoid numerical difficulties, mainly due to the need to compute numerically multiple integrals involved in the likelihood, several approximations of the likelihood have been proposed (Pinheiro and Bates, 2000) but they may lead to inconsistent estimations (Ding and Wu, 2001 ). The problem is even more important when no closed-form solution is available, making numerical derivatives of the likelihood unstable and classical softwares inadequate (Putter et al., 2002; Huang et al., 2006) .
The aim of our work was to develop a maximum likelihood approach to this problem based on an adaptation of a Newton-like method. We propose 3 a method for calculating with a good precision the likelihood and its score in ODE models; we show that a Newton-like method using only the first derivatives is adequate. We illustrate this approach with data from a clinical trial of antiviral therapy using a rather complex non-linear ODE model with five components. We were able to take into account left-censored data coming from the detection limits in the assays used for quantifying plasma HIV RNA level (viral load). In fact, ignoring this censoring leads to important biases in the estimation (Thiébaut et al., 2006) . The paper is organized as follows. In section 2, we describe the general population ODE model together with the observations we get from this model; in section 3, we present our inference approach, that is the likelihood and our maximization algorithm. In section 4, we describe an HIV dynamics model. In section 5, we analyse the data of the ALBI ANRS 070 trial. We show in section 6 that the algorithm works well through a simulation study.
Statistical Model

Model for the system
Let us consider an ODE model for a population of subjects. For subject i with i = 1, ...n, this can be written:
where
′ is the vector of the K state variables (or components). We write X(t, ξ (i) ) = X (i) (t) to underline that ξ (i) completely determines the trajectories X (i) (t). We assume that f and h are twice differentiable with respect to
is a vector of p individual parameters which appear naturally in the ODE 4 system and have generally a biological interpretation. We introduce a parsimonious model for ξ (i) to allow inter-individual variability: the variability may be explained, through explanatory variables, or unexplained, and this is accounted for by random effects. Similarly to generalized (mixed) linear models, we introduce a link function which relates ξ (i) to a linear model involving explanatory variables and random effects. For sake of simplicity we restrict to component-wise transforms:
where φ l is the intercept, z 
Model for the observations
It often happens that not all the components of the system can be observed. Functions g m (.), m = 1, . . . , M of R K to R are introduced to link the potential observations to the original system; they are assumed to be twice differentiable. These functions allow to observe only some of the components of the original system, or observation of combinations of several components:
for instance the model may distinguish between non-infected and infected CD4, but only the total number of CD4 is observed. These functions may also include known transformations such as the logarithm; the g m (.) are thus 5 assumed completely known and will be called the observable components.
Let Y ijm denote the jth measurements of the mth observable component for subject i at time t ijm ; we assume that:
where the ǫ ijm are independent Gaussian with zero mean and variances σ 
where Φ is the cumulative distribution function of the standard univariate
where φ is the multivariate normal density of N (0, I q ). We will denote
and observed individual log-likelihoods, respectively. The global observed
The integrand in (4) is centered and scaled as suggested for the adaptive Gaussian quadrature in Pinheiro and Bates (2000) and the integral is then computed with an efficient algorithm developed by Genz and Keister (1996) (see Web Appendix A & C for more details).
Algorithm of Likelihood Maximization
For likelihood inference, we propose a Newton-like method which uses only the first derivatives of the log-likelihood (the score).
Computation of the score
The computation of the score proceeds in two stages: first compute the score of the full likelihood given random effects; second compute the score of the observed likelihood by integration using the relationships given by Louis 7 (1982) and generalized by Commenges and Rondeau (2006) ; this approach was used by Hedeker and Gibbons (1994) in another context. For simplicity, we assume in this section that there is no censored data. For subject i
components of the full score can be written as follows:
Using the fact that:
, the computation of the full score requires to solve numerically the p systems of sensitivity equations
(see example in the Web Appendix B).
Then the observed scores can be deduced by Louis' formula:
The integrals can be computed by adaptive Gaussian quadrature using the same transformation as for the computation of L O i . Then, the global ob-
The maximization algorithm
The Newton-Raphson method, or the more robust Marquardt algorithm (Marquardt, 1963) , is the most efficient algorithm when the log-likelihood is not too far from a quadratic function. This approach requires to compute the score U and the Hessian H at each current point θ k of the maximization procedure. Although a semi-analytical expression for the Hessian could be obtained with the same two-stages approach as for the score, the computational burden would become unbearable and we propose to use an iterative method
(where ν is a weighting coefficient). We have that n −1 G(θ) converges toward n −1 I(θ * ) where I(θ * ) is the information matrix under the true probability, θ * being the true parameter value. Thus G(θ k ) should be a good approximation of H(θ k ) near the maximum since n −1 H(θ) itself converges toward n −1 I(θ * ).
As for convergence criterion we use
asymptotically a χ 2 p distribution; this gives an idea of which value should be considered as "small". Once the convergence is obtained one may use G(θ) as an estimator of I(θ * ) to build confidence intervals and Wald tests. However sinceθ is the value for which U (θ) = 0, we may expect that the variance of U computed inθ is a negatively biased estimate of its variance at θ * (that is
. This bias is difficult to estimate in general. In the linear model with known error variance, it can be shown that
where β is the vector of regression coefficients. By analogy we propose to esti-
G(θ). The whole algorithm (iteration and convergence criterion) has the property that it is invariant under any affine transformation of the parameters. Details about the implementation may be found in 9 the Web Appendix C.
Expectations & Predictions
The expected trajectory can be obtained by simulating a sample of subjects and averaging, for each time and each marker, over their values.
Also, individual predicted trajectories can be computed asX The primary outcome measure defined in the study protocol was the antiretroviral effect as measured by the mean change in HIV RNA level between baseline and 24 weeks by use of the ultra-sensitive PCR assay with 10 lower limit of quantification of 50 copies/mL (1.7 log 10 ). In the main analysis of Molina et al. (1999) , HIV RNA values reported as < 50 copies/mL were considered equivalent to 50 copies/mL; 51 patients were included in each treatment group. Over the 24-week period, HIV RNA level declined in the two groups, with mean (SE) decreases at the end of the study of 1.26 (0.09) log 10 copies/mL in the AZT+3TC group and 2.26 (0.11) log 10 copies/mL in the ddI+d4T group. The mean increase in CD4 count was larger in ddI+d4T group than in AZT+3TC group (124 cells/µL vs. 62 cells/µL, p=0.012).
A mathematical model for HIV dynamics
Conventional models for HIV dynamics have involved target cells (mainly uninfected CD4), infected cells producing viruses, and circulating viruses (Perelson et al., 1996) . Because the activation of CD4 has been recognized as a central role in HIV pathogenesis (Grossman et al., 2000) , the activated state is worth distinguishing. Actually, activated cells make a better target than quiescent cells and viral replication is rapid and efficient in activated cells (Ribeiro et al., 2002) . Also, it is useful to distinguish infectious and non-infectious virions because non-infectious virions are predominant (Chun et al., 1997) . In the ALBI ANRS 070 trial, antiretroviral therapy included reverse transcriptase inhibitors only. This type of antiretroviral drugs limits cell infection by inhibiting reverse transcription of HIV RNA and thus was modeled by limiting the new production of T * through the parameter η. The 11 model can be written as:
where Q, T , T * are quiescent non-infected, activated non-infected, and ac- The definition of each parameter of this system of non-linear differential equations is reported in Table 1 . We make the assumption that before initiation of antiretroviral treatment the values of the state variables are that of steady state of the ODE system with η = 0. This assumption implies that the treatment is initiated far from initial infection. The steady state assumption leads to the following initial conditions (where t = 0 refers to treatment initiation):
The statistical model
We used the structure defined in section 2 to estimate the parameters of the biological model (5). Because the study was not designed for dynamic 12 modelling, it was not possible to estimate all the parameters. In the present study, the first measurement after therapy was performed four weeks later rather than several hours in some studies of virus dynamics (Ho et al., 1995) .
We consequently chose to fix the set (µ Q , µ v , ρ, ω) whose estimates can be found in the literature (Table 1 ). The parameter γ was at the limit of non-identifiability: we determined it in a plausible range of values by profile likelihood.
The vector of natural parameters for subject i was then:
The link functions were the log transform for all parameters (because they must be positive) except for η (i) for which we took the inverse logistic func-
We introduced in the model only one explanatory variable z (i) , which represented the treatment group:
for the AZT+3TC group and z (i) = 1 for the ddI+d4T group.η 0 represented the treatment effect for AZT+3TC in the logistic scale and β represented the differential effect of ddI+d4T relative to AZT+3TC in the logistic scale:
Concerning the selection of random effects, we favored a forward selection strategy because the number of random effects is limited by the amount of information available as well as by the curse of dimensionality (the dimension of the multiple integrals is equal to the number q of random effects). Starting with the model without random effect, we introduced one random effect successively on each parameter and selected the one which most increased the likelihood; then we proceeded to include a second random effect according to the same criterion, and so on until the model with q random effects was not rejected by a likelihood ratio test (the distribution of the likelihood ratio 13 statistic being a mixture of chi-square distributions).
Observable components g 1 and g 2 were transforms of the HIV RNA concentration and the total CD4 count respectively with g 1 = log 10 (V I + V N I ) and g 2 = (Q + T + T * ) 0.25 . These transformations of HIV markers values are commonly used for achieving normality and homoscedasticity of measurement error distributions (Thiébaut et al., 2003) .
[ Table 1 about here.]
Analysis of the ALBI ANRS 070 data
We estimated the parameters of the statistical model described above using repeated measurements of both the virus load and the total CD4 count from the ALBI ANRS 070 data. The model for the observations (3) can be given more explicitly:
We tried different starting values (increasing the variance parameters values by 10 folds, intercept value from 10 % to 100 %) and we obtained the same convergence point up to small variations on the third signifcant digit.
The value forγ obtained by profile likelihood wasγ = −3. The estimates of the model parameters are shown in Table 2 .
[ Table 2 
Simulation study
In this section, we aim at analyzing the efficiency of our algorithm in term of success of convergence, precision and validity of estimators. Data were simulated using values from the analysis of the ALBI ANRS 070 trial presented in the former section.γ was held fixed at the valueγ = −3. We simulated trials of 100 patients, according to the typical schedule of the ANRS ALBI 070 trial. For each parameter, absolute bias, confidence interval coverage, empirical standard deviations and estimated standard deviations were calculated. Of note, the absolute bias of log transformed parameters can be interpreted as a relative bias of parameters on natural scale. The initial values were selected as follows:
* where * refers to values in Table 2 . The maximum number of iterations was fixed at 25 for restricting the duration of the simulation study. Convergence before 25 iterations was successfully reached in 93% of simulations, and the computation time was between two and three hours per simulation. In the simulations where convergence was not achieved, convergence criteria value indicated that the algorithm might converge but with further iterations. Results from 100 successful convergences are summarized in Table 8 . The biases were small in regard of the complexity of the model; the coverage rates of 16 the confidence intervals were good and the variances were well estimated.
Although the results of this simulation study show that the algorithm is efficient when the model is well specified, this does not warrant that it will be so for real data. Furthermore, more general conclusions on the robustness and efficiency of the algorithm would need an extension of the simulation study over a larger set of plausible values for θ.
[ Table 3 about here.]
Discussion
In this paper, we presented a robust method to fit non-linear mixed effects models based on differential equations for which no closed-form is available.
This approach may be applied to any NLME models. Nevertheless, the method requires some computational skills whereas simpler methods are often sufficient for usual NLME models (with closed-form). The approach was One of the limitations of the present application is the impossibility of estimating all parameters. In fact, the estimation of all parameters would need more intensive schedules and/or the measurements of more compartments such as activated CD4. However, a sensitivity analysis allowed us to conclude that the estimate of the difference in treatment effects between the two groups was robust.
We conclude that the use of such models to analyze clinical trial data could help in having a better understanding of the treatment effect; however, estimating all model parameters requires richer information than usual and this needs to be planned in the study protocol.
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